Aspira Women's Health Inc. (AWHL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 900K 1.8M 2.7M Q3 '21: 1.7M Q4 '21: 1.9M Q1 '22: 1.9M Q2 '22: 2.1M Q3 '22: 2.1M Q4 '22: 2.2M Q1 '23: 2.3M Q2 '23: 2.5M Q3 '23: 2.2M Q4 '23: 2.1M Q1 '24: 2.2M Q2 '24: 2.4M Q3 '24: 2.3M Q4 '24: 2.3M Q1 '25: 2.3M Q2 '25: 2.4M Q3 '25: 2.3M Q4 '25: 2.2M Q1 '26: 2M Q2 '26: 2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 600K 1.2M 1.8M Q3 '21: 749K Q4 '21: 1M Q1 '22: 961K Q2 '22: 966K Q3 '22: 1.2M Q4 '22: 1.2M Q1 '23: 1.2M Q2 '23: 1.6M Q3 '23: 1.3M Q4 '23: 1.2M Q1 '24: 1.2M Q2 '24: 1.4M Q3 '24: 1.4M Q4 '24: 1.5M Q1 '25: 1.6M Q2 '25: 1.5M Q3 '25: 1.4M Q4 '25: 1.4M Q1 '26: 1.1M Q2 '26: 1.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: -9.7M Q4 '21: -8.9M Q1 '22: -9.2M Q2 '22: -8.2M Q3 '22: -8.6M Q4 '22: -5.1M Q1 '23: -6.3M Q2 '23: -4.3M Q3 '23: -4.1M Q4 '23: -4.1M Q1 '24: -4.7M Q2 '24: -4.4M Q3 '24: -3.7M Q4 '24: -3.4M Q1 '25: -3.2M Q2 '25: -1.8M Q3 '25: -1.6M Q4 '25: -1.3M Q1 '26: -2.2M Q2 '26: -1.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: -9.7M Q4 '21: -9M Q1 '22: -9.3M Q2 '22: -8.2M Q3 '22: -7.8M Q4 '22: -4.6M Q1 '23: -6.6M Q2 '23: -2.3M Q3 '23: -4.7M Q4 '23: -3.1M Q1 '24: -4.6M Q2 '24: -3.5M Q3 '24: -3.5M Q4 '24: -1.4M Q1 '25: -1.9M Q2 '25: -2.7M Q3 '25: -4.9M Q4 '25: -3.4M Q1 '26: 676K Q2 '26: -2.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 400K 800K 1.2M Q3 '21: 917K Q4 '21: 837K Q1 '22: 932K Q2 '22: 1.1M Q3 '22: 916K Q4 '22: 913K Q1 '23: 1.1M Q2 '23: 941K Q3 '23: 910K Q4 '23: 911K Q1 '24: 939K Q2 '24: 1M Q3 '24: 902K Q4 '24: 860K Q1 '25: 719K Q2 '25: 870K Q3 '25: 922K Q4 '25: 790K Q1 '26: 896K Q2 '26: 915K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: -8M Q4 '21: -7.6M Q1 '22: -10.2M Q2 '22: -6.3M Q3 '22: -7.5M Q4 '22: -7.1M Q1 '23: -5.7M Q2 '23: 3.4M Q3 '23: 3.3M Q4 '23: -3.5M Q1 '24: -4.4M Q2 '24: -3.7M Q3 '24: -2.9M Q4 '24: -1M Q1 '25: -3.1M Q2 '25: -1.7M Q3 '25: -212K Q4 '25: -2M Q1 '26: -359K Q2 '26: -2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q2 '20: -3.5M Q3 '20: -3.2M Q4 '20: -5M Q1 '21: -5.3M Q2 '21: -6.6M Q3 '21: -8M Q4 '21: -7.7M Q1 '22: -10.3M Q2 '22: -6.3M Q3 '22: -7.6M Q4 '22: -7.2M Q1 '23: -5.7M Q2 '23: 3.4M Q3 '23: 3.3M Q4 '23: -3.5M Q1 '24: -4.5M Q2 '24: -3.8M Q3 '24: -2.9M Q4 '24: -1M Q4 '25: -2M Q3 '20 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q2 '21: 112M Q3 '21: 112.1M Q1 '22: 7.5M Q2 '22: 7.5M Q3 '22: 7.8M Q1 '23: 8.3M Q2 '23: 8.4M Q3 '23: 9.8M Q1 '24: 11.8M Q2 '24: 12.5M Q3 '24: 15.4M Q1 '25: 21.6M Q2 '25: 35.6M Q3 '25: 36.4M Q1 '26: 45.8M Q2 '26: 44.2M Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-9.00 -6.00 -3.00 0.00 3.00 6.00 9.00 Q1 '21: -0.19 Q2 '21: -0.21 Q3 '21: -0.26 Q4 '21: -4.27 Q1 '22: -5.46 Q2 '22: -6.50 Q3 '22: -7.41 Q4 '22: -3.86 Q1 '23: -3.41 Q2 '23: -2.59 Q3 '23: -2.07 Q4 '23: -1.82 Q1 '24: -1.42 Q2 '24: -1.42 Q3 '24: -1.17 Q4 '24: -0.95 Q1 '25: -0.65 Q2 '25: -0.44 Q3 '25: -0.34 Q4 '25: -0.36 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.